Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Ramesh A. Shivdasani, Tomer Adar et al.|Nature Medicine|2019Cited by 185
DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatmentElfi B. Conemans, Menno R. Vriens|European Journal of Endocrinology|2018Cited by 36
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Ramesh A. Shivdasani, Charles B. Epstein et al.|Nature Medicine|2019Cited by 5